U.S. Office REITs Stock News

NasdaqGM:CHRS
NasdaqGM:CHRSBiotechs

A Look At Coherus Oncology (CHRS) Valuation After Its US$64.9 Million Follow On Equity Offering

Follow on offering sets the stage Coherus Oncology (CHRS) has filed a follow on equity offering of about US$64.9 million through an at the market program. This is a material move that directly affects funding plans and existing shareholders. See our latest analysis for Coherus Oncology. The follow on offering arrives after a sharp rebound in sentiment, with a 1 month share price return of 53.73% and year to date share price return of 50.37%. However, the 5 year total shareholder return of an...
NYSE:PD
NYSE:PDSoftware

PagerDuty Refreshes Leadership As Share Slump Puts Execution In Focus

PagerDuty appointed Scott Aronson to its Board of Directors. The company also named Chris Ferro as Chief Legal Officer. Both executives bring long running experience in enterprise technology and Silicon Valley legal work. PagerDuty, NYSE:PD, is making leadership changes as its share price sits at $11.17 and has seen a 40.8% decline over the past year and a 77.1% decline over five years. In that context, adding Scott Aronson to the board and Chris Ferro as Chief Legal Officer appears focused...
NasdaqGS:EBC
NasdaqGS:EBCBanks

Eastern Bankshares (EBC) Net Interest Margin Strength Tests Premium P/E Bullish Narratives

Eastern Bankshares (EBC) closed out FY 2025 with Q4 revenue of US$278.6 million and basic EPS of US$0.46, alongside net income of US$99.5 million, setting a clear marker for how the year ended on both the top and bottom line. Over recent periods, revenue has ranged from US$156.4 million in Q3 2024 to US$278.6 million in Q4 2025, while basic EPS has moved between a loss of US$1.09 in Q1 2025 and a profit of US$0.53 in Q3 2025. This gives investors a broad view of how earnings power has shifted...